Actively Recruiting
Construction of a Database for TMA
Led by The First Affiliated Hospital of Soochow University · Updated on 2022-12-02
500
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.
CONDITIONS
Official Title
Construction of a Database for TMA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Elevated lactate dehydrogenase more than twice the baseline value
- Platelet count less than 20 or decreased by more than 50% within 24 hours
- More than 2% schistocytes visible on peripheral blood smear or pathological evidence of extensive micro thrombosis
You will not qualify if you...
- Unable or unwilling to cooperate with the study procedures as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215006
Actively Recruiting
Research Team
Y
Yue Han, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here